InsiderClue
Insiders · Profile

ORBIMED ADVISORS LLC

Director at BlossomHill Therapeutics · Director at Braveheart Bio · Director at Scribe Therapeutics · and 42 more. Filing since 8 Feb 2011. CIK 0001055951

BLSM BlossomHill Therapeutics, Inc. Director · 1 trade BRVE Braveheart Bio, Inc. Director · 1 trade SCTX Scribe Therapeutics, Inc. Director · 1 trade SION Sionna Therapeutics, Inc. Director · 21 trades ELVN Enliven Therapeutics, Inc. 10% owner · 5 trades FIXX Q32 Bio Inc. Director · 1 trade PRLD Prelude Therapeutics Inc Director · 3 trades TRAW Traws Pharma, Inc. 10% owner · 1 trade ACET Adicet Bio, Inc. 10% owner · 6 trades PMVP PMV Pharmaceuticals, Inc. 10% owner · 8 trades STTK Shattuck Labs, Inc. Director · 1 trade CRVS Corvus Pharmaceuticals, Inc. Director · 21 trades PASG Passage BIO, Inc. 10% owner · 37 trades NPCE NeuroPace Inc 10% owner · 16 trades XTNT Xtant Medical Holdings, Inc. 10% owner · 2 trades CMPX Compass Therapeutics, Inc. Director · 10 trades EWTX Edgewise Therapeutics, Inc. Director · 5 trades IRON Disc Medicine, Inc. Director · 13 trades MBX MBX Biosciences, Inc. Director · 3 trades UPB Upstream Bio, Inc. Director · 1 trade SPRY ARS Pharmaceuticals, Inc. Director · 7 trades KROS Keros Therapeutics, Inc. Director · 2 trades TELA TELA Bio, Inc. 10% owner · 7 trades AVBP ArriVent BioPharma, Inc. Director · 1 trade DMRA Damora Therapeutics, Inc. 10% owner · 13 trades ARQT Arcutis Biotherapeutics, Inc. 10% owner · 6 trades IMA ImageneBio, Inc. Director · 4 trades JANX Janux Therapeutics, Inc. Director · 4 trades ORIC Oric Pharmaceuticals, Inc. Director · 15 trades WHWK Whitehawk Therapeutics, Inc. 10% owner · 3 trades CALC CalciMedica, Inc. 10% owner · 1 trade INSP Inspire Medical Systems, Inc. Director · 15 trades ALEC Alector, Inc. 10% owner · 18 trades NXTC NextCure, Inc. Director · 1 trade SIBN SI-BONE, Inc. Director · 1 trade RYTM RHYTHM PHARMACEUTICALS, INC. 10% owner · 4 trades PVLA PALVELLA THERAPEUTICS, INC. 10% owner · 5 trades GKOS GLAUKOS Corp Director · 17 trades KALA KALA BIO, Inc. 10% owner · 14 trades SYRE Spyre Therapeutics, Inc. 10% owner · 3 trades RNAC Cartesian Therapeutics, Inc. Director · 1 trade NTLA Intellia Therapeutics, Inc. Director · 1 trade SUPN SUPERNUS PHARMACEUTICALS, INC. 10% owner · 5 trades AMRN AMARIN CORP PLC\UK Director · 40 trades PCRX Pacira BioSciences, Inc. 10% owner · 11 trades
Company
Date
Role
Action
Shares
Amount
Of holding
BLSM BlossomHill Therapeutics, Inc.
10 Aug 2026
Director
Bought
625,000
$10.00M
29.9%
BRVE Braveheart Bio, Inc.
7 Aug 2026
Director
Bought
1,940,000
$34.92M
19.5%
SCTX Scribe Therapeutics, Inc.
27 Jul 2026
Director
Bought
1,000,000
$15.00M
287%
SION Sionna Therapeutics, Inc.
7 Jul 2026
Director
Sold on a plan
85,918
$3.85M
3.4%
SION Sionna Therapeutics, Inc.
30 Jun 2026
Director
Sold on a plan
115,844
$5.27M
4.3%
ELVN Enliven Therapeutics, Inc.
22 Jun 2026
10% owner
Sold at will
860,123
$39.01M
79.7%
ELVN Enliven Therapeutics, Inc.
15 Jun 2026
10% owner
Sold at will
281,408
$12.67M
53.4%
FIXX Q32 Bio Inc.
28 May 2026
Director
Bought
1,875,000
$15.00M
115%
SION Sionna Therapeutics, Inc.
27 May 2026
Director
Sold on a plan
101
$4.49K
0.0%
SION Sionna Therapeutics, Inc.
11 May 2026
Director
Sold on a plan
184,639
$8.53M
6.5%
SION Sionna Therapeutics, Inc.
8 May 2026
Director
Sold on a plan
59,767
$2.66M
2.0%
SION Sionna Therapeutics, Inc.
7 May 2026
Director
Sold on a plan
48,546
$2.17M
1.6%
PRLD Prelude Therapeutics Inc
21 Apr 2026
Director
Bought
2,815,315
$12.50M
31.3%
SION Sionna Therapeutics, Inc.
18 Apr 2026
Director
Sold on a plan
2,948
$131.24K
0.1%
SION Sionna Therapeutics, Inc.
17 Apr 2026
Director
Sold on a plan
52,397
$2.34M
1.7%
SION Sionna Therapeutics, Inc.
16 Apr 2026
Director
Sold on a plan
226,906
$10.29M
7.0%
TRAW Traws Pharma, Inc.
16 Apr 2026
10% owner
Bought
597,729
$998.21K
98.7%
SION Sionna Therapeutics, Inc.
15 Apr 2026
Director
Sold on a plan
235,863
$10.53M
6.8%
SION Sionna Therapeutics, Inc.
14 Apr 2026
Director
Sold on a plan
47,814
$2.13M
1.4%
ACET Adicet Bio, Inc.
8 Apr 2026
10% owner
Sold at will
72,939
$468.08K
100%
ACET Adicet Bio, Inc.
7 Apr 2026
10% owner
Sold at will
31,719
$206.77K
49.4%
SION Sionna Therapeutics, Inc.
3 Feb 2026
Director
Sold on a plan
29,063
$1.30M
0.8%
SION Sionna Therapeutics, Inc.
2 Feb 2026
Director
Sold on a plan
1,890
$84.24K
0.1%
SION Sionna Therapeutics, Inc.
24 Dec 2025
Director
Sold on a plan
33,356
$1.49M
0.9%
SION Sionna Therapeutics, Inc.
19 Dec 2025
Director
Sold on a plan
875
$38.93K
0.0%
SION Sionna Therapeutics, Inc.
18 Dec 2025
Director
Sold on a plan
100
$4.45K
0.0%
SION Sionna Therapeutics, Inc.
17 Dec 2025
Director
Sold on a plan
900
$40.05K
0.0%
SION Sionna Therapeutics, Inc.
26 Nov 2025
Director
Sold on a plan
1,600
$71.18K
0.0%
SION Sionna Therapeutics, Inc.
25 Nov 2025
Director
Sold on a plan
11,890
$530.29K
0.3%
SION Sionna Therapeutics, Inc.
24 Nov 2025
Director
Sold on a plan
94,583
$4.21M
2.6%
PMVP PMV Pharmaceuticals, Inc.
23 Oct 2025
10% owner
Sold at will
1,000,000
$1.52M
16.7%
ACET Adicet Bio, Inc.
8 Oct 2025
10% owner
Bought
5,000,000
$5.00M
124%
PMVP PMV Pharmaceuticals, Inc.
10 Sep 2025
10% owner
Sold at will
500,000
$900.00K
7.7%
STTK Shattuck Labs, Inc.
25 Aug 2025
Director
Bought
6,306,127
$5.47M
opened
CRVS Corvus Pharmaceuticals, Inc.
27 Jun 2025
Director
Sold at will
1,176,332
$4.89M
14.1%
PASG Passage BIO, Inc.
26 Jun 2025
10% owner
Sold at will
213,257
$70.37K
3.4%
PASG Passage BIO, Inc.
25 Jun 2025
10% owner
Sold at will
138,800
$45.80K
2.2%
PASG Passage BIO, Inc.
24 Jun 2025
10% owner
Sold at will
231,600
$81.06K
3.5%
NPCE NeuroPace Inc
14 May 2025
10% owner
Sold at will
168,136
$2.67M
4.9%
PASG Passage BIO, Inc.
24 Apr 2025
10% owner
Sold at will
68,195
$21.82K
1.0%
PASG Passage BIO, Inc.
23 Apr 2025
10% owner
Sold at will
89,328
$30.37K
1.3%
PASG Passage BIO, Inc.
22 Apr 2025
10% owner
Sold at will
78,049
$26.54K
1.1%
PASG Passage BIO, Inc.
17 Apr 2025
10% owner
Sold at will
77,090
$25.44K
1.1%
PASG Passage BIO, Inc.
16 Apr 2025
10% owner
Sold at will
61,638
$20.34K
0.9%
PASG Passage BIO, Inc.
15 Apr 2025
10% owner
Sold at will
10,326
$3.92K
0.1%
XTNT Xtant Medical Holdings, Inc.
10 Apr 2025
10% owner
Sold at will
73,114,592
$30.71M
100%
CMPX Compass Therapeutics, Inc.
9 Apr 2025
Director
Sold at will
3,571,428
$5.68M
100%
EWTX Edgewise Therapeutics, Inc.
3 Apr 2025
Director
Bought
496,771
$10.00M
3.5%
IRON Disc Medicine, Inc.
24 Mar 2025
Director
Sold at will
5,738
$310.48K
3.0%
IRON Disc Medicine, Inc.
21 Mar 2025
Director
Sold at will
10,011
$540.59K
5.1%
IRON Disc Medicine, Inc.
20 Mar 2025
Director
Sold at will
2,762
$149.18K
1.4%
IRON Disc Medicine, Inc.
19 Mar 2025
Director
Sold at will
39,656
$2.14M
17.3%
IRON Disc Medicine, Inc.
12 Mar 2025
Director
Sold at will
83,182
$4.53M
30.0%
IRON Disc Medicine, Inc.
11 Mar 2025
Director
Sold at will
27,056
$1.46M
11.7%
IRON Disc Medicine, Inc.
10 Mar 2025
Director
Sold at will
202,146
$10.97M
49.2%
MBX MBX Biosciences, Inc.
18 Feb 2025
Director
Bought
143,170
$1.55M
4.6%
MBX MBX Biosciences, Inc.
14 Feb 2025
Director
Bought
47,502
$468.79K
1.5%
SION Sionna Therapeutics, Inc.
10 Feb 2025
Director
Bought
550,000
$9.90M
17.4%
PASG Passage BIO, Inc.
14 Jan 2025
10% owner
Sold at will
79,024
$47.41K
1.1%
PASG Passage BIO, Inc.
13 Jan 2025
10% owner
Sold at will
17,986
$11.51K
0.3%
PASG Passage BIO, Inc.
10 Jan 2025
10% owner
Sold at will
126,209
$83.30K
1.7%
PASG Passage BIO, Inc.
8 Jan 2025
10% owner
Sold at will
75,007
$51.00K
1.0%
PASG Passage BIO, Inc.
7 Jan 2025
10% owner
Sold at will
52,536
$37.30K
0.7%
PASG Passage BIO, Inc.
6 Jan 2025
10% owner
Sold at will
19,481
$15.00K
0.3%
PASG Passage BIO, Inc.
20 Dec 2024
10% owner
Sold at will
230,321
$138.19K
3.0%
PASG Passage BIO, Inc.
11 Dec 2024
10% owner
Sold at will
80
$64.00
0.0%
PASG Passage BIO, Inc.
10 Dec 2024
10% owner
Sold at will
8,015
$6.41K
0.1%
PASG Passage BIO, Inc.
9 Dec 2024
10% owner
Sold at will
54,181
$45.51K
0.7%
PASG Passage BIO, Inc.
6 Dec 2024
10% owner
Sold at will
20,903
$17.14K
0.3%
PASG Passage BIO, Inc.
4 Dec 2024
10% owner
Sold at will
76,200
$60.20K
1.0%
UPB Upstream Bio, Inc.
15 Oct 2024
Director
Bought
825,000
$14.03M
22.1%
PASG Passage BIO, Inc.
19 Sep 2024
10% owner
Sold at will
39,300
$27.90K
0.5%
PASG Passage BIO, Inc.
18 Sep 2024
10% owner
Sold at will
25,631
$18.71K
0.3%
PASG Passage BIO, Inc.
17 Sep 2024
10% owner
Sold at will
111,400
$81.32K
1.4%
MBX MBX Biosciences, Inc.
16 Sep 2024
Director
Bought
750,000
$12.00M
31.1%
PASG Passage BIO, Inc.
16 Sep 2024
10% owner
Sold at will
63,100
$46.69K
0.8%
SPRY ARS Pharmaceuticals, Inc.
26 Aug 2024
Director
Sold at will
83,695
$1.09M
100%
SPRY ARS Pharmaceuticals, Inc.
23 Aug 2024
Director
Sold at will
69,500
$905.59K
45.4%
SPRY ARS Pharmaceuticals, Inc.
22 Aug 2024
Director
Sold at will
391,482
$5.07M
71.9%
SPRY ARS Pharmaceuticals, Inc.
21 Aug 2024
Director
Sold at will
407,700
$5.53M
42.8%
KROS Keros Therapeutics, Inc.
13 Aug 2024
Director
Sold at will
250,000
$11.00M
67.7%
TELA TELA Bio, Inc.
2 Jul 2024
10% owner
Sold at will
36,600
$166.16K
1.5%
TELA TELA Bio, Inc.
1 Jul 2024
10% owner
Sold at will
13,700
$64.12K
0.6%
TELA TELA Bio, Inc.
28 Jun 2024
10% owner
Sold at will
378,000
$1.79M
13.3%
IRON Disc Medicine, Inc.
17 Jun 2024
Director
Bought
83,334
$3.00M
9.7%
ELVN Enliven Therapeutics, Inc.
16 May 2024
Director
Sold at will
1,033,300
$22.88M
80.2%
NPCE NeuroPace Inc
3 May 2024
10% owner
Sold at will
4,674
$65.58K
0.1%
NPCE NeuroPace Inc
2 May 2024
10% owner
Sold at will
8,842
$123.88K
0.3%
NPCE NeuroPace Inc
1 May 2024
10% owner
Sold at will
15,690
$219.97K
0.5%
NPCE NeuroPace Inc
24 Apr 2024
10% owner
Sold at will
1,781
$25.04K
0.1%
NPCE NeuroPace Inc
23 Apr 2024
10% owner
Sold at will
21,791
$311.39K
0.6%
NPCE NeuroPace Inc
22 Apr 2024
10% owner
Sold at will
24,609
$345.76K
0.7%
NPCE NeuroPace Inc
19 Apr 2024
10% owner
Sold at will
18,253
$255.91K
0.5%
NPCE NeuroPace Inc
18 Apr 2024
10% owner
Sold at will
2,623
$36.88K
0.1%
NPCE NeuroPace Inc
17 Apr 2024
10% owner
Sold at will
300
$4.25K
0.0%
NPCE NeuroPace Inc
16 Apr 2024
10% owner
Sold at will
14,069
$197.11K
0.4%
NPCE NeuroPace Inc
12 Apr 2024
10% owner
Sold at will
23,101
$333.12K
0.7%
NPCE NeuroPace Inc
11 Apr 2024
10% owner
Sold at will
461,899
$6.69M
11.5%
AVBP ArriVent BioPharma, Inc.
30 Jan 2024
Director
Bought
444,444
$8.00M
41.6%
ACET Adicet Bio, Inc.
25 Jan 2024
Director
Bought
3,125,000
$7.50M
71.0%
EWTX Edgewise Therapeutics, Inc.
23 Jan 2024
Director
Bought
454,545
$5.00M
3.3%
IRON Disc Medicine, Inc.
18 Dec 2023
Director
Sold at will
1,724
$102.13K
100%
IRON Disc Medicine, Inc.
14 Dec 2023
Director
Sold at will
433,400
$24.60M
65.9%
IRON Disc Medicine, Inc.
13 Dec 2023
Director
Sold at will
106,700
$6.25M
27.5%
IRON Disc Medicine, Inc.
12 Dec 2023
Director
Sold at will
27,300
$1.64M
8.5%
PMVP PMV Pharmaceuticals, Inc.
22 Nov 2023
10% owner
Sold at will
87,786
$195.76K
100%
NPCE NeuroPace Inc
3 Oct 2023
10% owner
Sold at will
700
$6.31K
0.0%
NPCE NeuroPace Inc
2 Oct 2023
10% owner
Sold at will
7,614
$69.14K
0.2%
SPRY ARS Pharmaceuticals, Inc.
29 Aug 2023
Director
Bought
500,000
$3.10M
6.6%
DMRA Damora Therapeutics, Inc.
15 Aug 2023
10% owner
Sold at will
822,680
$617.01K
89.4%
DMRA Damora Therapeutics, Inc.
31 Jul 2023
10% owner
Sold at will
209,400
$628.20K
60.7%
DMRA Damora Therapeutics, Inc.
25 Jul 2023
10% owner
Sold at will
39,200
$114.46K
19.5%
DMRA Damora Therapeutics, Inc.
13 Jul 2023
10% owner
Sold at will
194,700
$467.28K
53.4%
PASG Passage BIO, Inc.
28 Jun 2023
10% owner
Bought
575,195
$483.16K
7.7%
ACET Adicet Bio, Inc.
27 Jun 2023
Director
Bought
875,000
$1.83M
18.2%
PASG Passage BIO, Inc.
27 Jun 2023
10% owner
Bought
617,382
$518.60K
9.0%
PRLD Prelude Therapeutics Inc
22 May 2023
Director
Bought
869,565
$5.00M
9.4%
TELA TELA Bio, Inc.
21 Apr 2023
10% owner
Sold at will
27,700
$260.66K
1.0%
TELA TELA Bio, Inc.
20 Apr 2023
10% owner
Sold at will
28,300
$266.87K
1.0%
TELA TELA Bio, Inc.
19 Apr 2023
10% owner
Sold at will
136,000
$1.26M
4.5%
DMRA Damora Therapeutics, Inc.
17 Apr 2023
10% owner
Sold at will
13,089
$25.79K
6.8%
DMRA Damora Therapeutics, Inc.
14 Apr 2023
10% owner
Sold at will
41,446
$77.09K
18.7%
DMRA Damora Therapeutics, Inc.
13 Apr 2023
10% owner
Sold at will
13,946
$25.38K
7.1%
DMRA Damora Therapeutics, Inc.
12 Apr 2023
10% owner
Sold at will
2,363
$4.28K
1.3%
DMRA Damora Therapeutics, Inc.
11 Apr 2023
10% owner
Sold at will
13,946
$25.38K
7.1%
DMRA Damora Therapeutics, Inc.
10 Apr 2023
10% owner
Sold at will
51,228
$91.70K
21.6%
DMRA Damora Therapeutics, Inc.
6 Apr 2023
10% owner
Sold at will
9,665
$19.33K
4.9%
DMRA Damora Therapeutics, Inc.
5 Apr 2023
10% owner
Sold at will
92,965
$202.66K
33.2%
IRON Disc Medicine, Inc.
15 Feb 2023
Director
Bought
108,696
$2.50M
10.0%
CMPX Compass Therapeutics, Inc.
8 Nov 2022
Director
Bought
402,000
$1.29M
2.7%
EWTX Edgewise Therapeutics, Inc.
16 Sep 2022
Director
Bought
484,496
$5.00M
3.6%
ARQT Arcutis Biotherapeutics, Inc.
24 Jun 2022
10% owner
Sold, plan not stated
341,971
$7.29M
45.2%
IMA ImageneBio, Inc.
24 Jun 2022
Director
Sold, plan not stated
162,000
$803.98K
7.5%
IMA ImageneBio, Inc.
23 Jun 2022
Director
Sold, plan not stated
23,419
$86.88K
1.2%
IMA ImageneBio, Inc.
22 Jun 2022
Director
Sold, plan not stated
66,806
$237.16K
3.4%
PMVP PMV Pharmaceuticals, Inc.
26 May 2022
10% owner
Sold, plan not stated
26,253
$418.21K
23.0%
EWTX Edgewise Therapeutics, Inc.
18 May 2022
Director
Bought
138,000
$994.98K
1.0%
CMPX Compass Therapeutics, Inc.
13 May 2022
Director
Bought
30,722
$76.50K
0.2%
CMPX Compass Therapeutics, Inc.
12 May 2022
Director
Bought
97,094
$228.17K
0.7%
CMPX Compass Therapeutics, Inc.
11 May 2022
Director
Bought
64,700
$115.81K
0.4%
CMPX Compass Therapeutics, Inc.
10 May 2022
Director
Bought
24,447
$39.12K
0.2%
CMPX Compass Therapeutics, Inc.
9 May 2022
Director
Bought
90,712
$141.51K
0.6%
CMPX Compass Therapeutics, Inc.
6 May 2022
Director
Bought
10,200
$16.63K
0.1%
PASG Passage BIO, Inc.
4 May 2022
10% owner
Bought
303,500
$588.79K
4.6%
PASG Passage BIO, Inc.
3 May 2022
10% owner
Bought
221,500
$427.50K
3.5%
ARQT Arcutis Biotherapeutics, Inc.
8 Apr 2022
10% owner
Sold, plan not stated
200,000
$4.14M
30.7%
ARQT Arcutis Biotherapeutics, Inc.
7 Apr 2022
10% owner
Sold, plan not stated
344,996
$7.13M
38.4%
ARQT Arcutis Biotherapeutics, Inc.
6 Apr 2022
10% owner
Sold, plan not stated
333,204
$6.89M
31.3%
PMVP PMV Pharmaceuticals, Inc.
31 Mar 2022
10% owner
Sold, plan not stated
34,500
$730.37K
100%
PMVP PMV Pharmaceuticals, Inc.
30 Mar 2022
10% owner
Sold, plan not stated
75,000
$1.68M
68.5%
PMVP PMV Pharmaceuticals, Inc.
29 Mar 2022
10% owner
Sold, plan not stated
365,000
$7.85M
76.9%
PASG Passage BIO, Inc.
20 Jan 2022
10% owner
Bought
369,100
$2.00M
5.9%
PASG Passage BIO, Inc.
19 Jan 2022
10% owner
Bought
43,300
$221.26K
0.7%
PASG Passage BIO, Inc.
18 Jan 2022
10% owner
Bought
114,700
$626.26K
1.9%
PASG Passage BIO, Inc.
14 Jan 2022
10% owner
Bought
10,300
$57.68K
0.2%
PASG Passage BIO, Inc.
13 Jan 2022
10% owner
Bought
41,800
$230.74K
0.7%
PASG Passage BIO, Inc.
12 Jan 2022
10% owner
Bought
100,000
$565.00K
1.7%
PASG Passage BIO, Inc.
11 Jan 2022
10% owner
Bought
8,200
$45.35K
0.1%
JANX Janux Therapeutics, Inc.
29 Dec 2021
Director
Sold, plan not stated
40,400
$820.12K
14.9%
JANX Janux Therapeutics, Inc.
21 Dec 2021
Director
Sold, plan not stated
119,400
$2.27M
33.7%
JANX Janux Therapeutics, Inc.
16 Dec 2021
Director
Sold, plan not stated
393,300
$7.50M
61.5%
CMPX Compass Therapeutics, Inc.
4 Nov 2021
Director
Bought
5,357,143
$18.75M
58.6%
CRVS Corvus Pharmaceuticals, Inc.
20 Sep 2021
Director
Sold, plan not stated
1,109,644
$6.76M
13.8%
ELVN Enliven Therapeutics, Inc.
16 Jul 2021
Director
Bought
1,666,666
$10.00M
opened
JANX Janux Therapeutics, Inc.
15 Jun 2021
Director
Bought
705,853
$12.00M
34.4%
NPCE NeuroPace Inc
21 Apr 2021
10% owner
Bought
235,000
$4.00M
opened
IMA ImageneBio, Inc.
30 Mar 2021
Director
Bought
423,400
$6.77M
23.9%
EWTX Edgewise Therapeutics, Inc.
30 Mar 2021
Director
Bought
359,375
$5.75M
2.8%
ORIC Oric Pharmaceuticals, Inc.
30 Mar 2021
Director
Sold, plan not stated
27,869
$666.91K
1.2%
ORIC Oric Pharmaceuticals, Inc.
29 Mar 2021
Director
Sold, plan not stated
75,555
$1.76M
3.3%
ORIC Oric Pharmaceuticals, Inc.
26 Mar 2021
Director
Sold, plan not stated
27,816
$664.25K
1.2%
ORIC Oric Pharmaceuticals, Inc.
25 Mar 2021
Director
Sold, plan not stated
51,523
$1.27M
2.2%
ORIC Oric Pharmaceuticals, Inc.
24 Mar 2021
Director
Sold, plan not stated
32,959
$817.38K
1.4%
ORIC Oric Pharmaceuticals, Inc.
23 Mar 2021
Director
Sold, plan not stated
3,992
$97.09K
0.2%
ORIC Oric Pharmaceuticals, Inc.
22 Mar 2021
Director
Sold, plan not stated
7,673
$203.10K
0.3%
ORIC Oric Pharmaceuticals, Inc.
19 Mar 2021
Director
Sold, plan not stated
21,275
$563.15K
0.9%
ORIC Oric Pharmaceuticals, Inc.
18 Mar 2021
Director
Sold, plan not stated
6,059
$169.83K
0.2%
ORIC Oric Pharmaceuticals, Inc.
17 Mar 2021
Director
Sold, plan not stated
18,790
$534.20K
0.8%
ORIC Oric Pharmaceuticals, Inc.
16 Mar 2021
Director
Sold, plan not stated
41,353
$1.15M
1.6%
ORIC Oric Pharmaceuticals, Inc.
15 Mar 2021
Director
Sold, plan not stated
89,210
$2.60M
3.4%
ORIC Oric Pharmaceuticals, Inc.
12 Mar 2021
Director
Sold, plan not stated
90,521
$2.74M
3.3%
ORIC Oric Pharmaceuticals, Inc.
11 Mar 2021
Director
Sold, plan not stated
58,551
$1.93M
2.1%
CRVS Corvus Pharmaceuticals, Inc.
17 Feb 2021
Director
Bought
1,285,714
$4.50M
19.0%
SPRY ARS Pharmaceuticals, Inc.
8 Dec 2020
Director
Bought
952,377
$20.00M
opened
SPRY ARS Pharmaceuticals, Inc.
8 Dec 2020
Director
Bought
238,100
$5.00M
88.4%
WHWK Whitehawk Therapeutics, Inc.
8 Dec 2020
10% owner
Sold, plan not stated
21,400
$41.94K
100%
DMRA Damora Therapeutics, Inc.
2 Nov 2020
Director
Bought
733,333
$11.00M
39.7%
ARQT Arcutis Biotherapeutics, Inc.
2 Oct 2020
Director
Bought
496,000
$12.40M
13.2%
PRLD Prelude Therapeutics Inc
25 Sep 2020
Director
Bought
1,236,800
$23.50M
opened
PMVP PMV Pharmaceuticals, Inc.
25 Sep 2020
Director
Bought
950,000
$17.10M
opened
CALC CalciMedica, Inc.
25 Sep 2020
10% owner
Bought
562,500
$9.00M
opened
INSP Inspire Medical Systems, Inc.
18 Aug 2020
Director
Sold, plan not stated
43,543
$4.73M
100%
INSP Inspire Medical Systems, Inc.
17 Aug 2020
Director
Sold, plan not stated
94,900
$10.20M
68.5%
INSP Inspire Medical Systems, Inc.
14 Aug 2020
Director
Sold, plan not stated
20,257
$2.21M
12.8%
INSP Inspire Medical Systems, Inc.
13 Aug 2020
Director
Sold, plan not stated
29,251
$3.22M
15.6%
INSP Inspire Medical Systems, Inc.
12 Aug 2020
Director
Sold, plan not stated
42,679
$4.59M
18.5%
INSP Inspire Medical Systems, Inc.
11 Aug 2020
Director
Sold, plan not stated
39,877
$4.22M
14.8%
INSP Inspire Medical Systems, Inc.
10 Aug 2020
Director
Sold, plan not stated
47,700
$5.02M
15.0%
INSP Inspire Medical Systems, Inc.
7 Aug 2020
Director
Sold, plan not stated
28,993
$3.08M
8.4%
CMPX Compass Therapeutics, Inc.
19 Jun 2020
Director
Bought
1,455,132
$7.28M
12.9%
ORIC Oric Pharmaceuticals, Inc.
24 Apr 2020
Director
Bought
281,250
$4.50M
opened
ALEC Alector, Inc.
16 Apr 2020
10% owner
Sold, plan not stated
62,183
$1.46M
3.2%
ALEC Alector, Inc.
14 Apr 2020
10% owner
Sold, plan not stated
23,231
$546.39K
1.2%
KROS Keros Therapeutics, Inc.
13 Apr 2020
Director
Bought
375,200
$6.00M
50.4%
ALEC Alector, Inc.
9 Apr 2020
10% owner
Sold, plan not stated
288,101
$6.85M
13.0%
ALEC Alector, Inc.
8 Apr 2020
10% owner
Sold, plan not stated
82,614
$1.95M
4.0%
ALEC Alector, Inc.
7 Apr 2020
10% owner
Sold, plan not stated
9,170
$211.83K
0.5%
ALEC Alector, Inc.
31 Mar 2020
10% owner
Sold, plan not stated
250,000
$6.13M
11.0%
ALEC Alector, Inc.
25 Mar 2020
10% owner
Sold, plan not stated
56,411
$1.39M
2.6%
ALEC Alector, Inc.
24 Mar 2020
10% owner
Sold, plan not stated
67,644
$1.65M
3.1%
ALEC Alector, Inc.
23 Mar 2020
10% owner
Sold, plan not stated
14,598
$380.28K
0.7%
ELVN Enliven Therapeutics, Inc.
12 Mar 2020
Director
Bought
937,500
$15.00M
opened
INSP Inspire Medical Systems, Inc.
6 Mar 2020
Director
Sold, plan not stated
500,000
$41.76M
59.0%
INSP Inspire Medical Systems, Inc.
3 Mar 2020
Director
Sold, plan not stated
500,000
$42.12M
37.1%
ALEC Alector, Inc.
2 Mar 2020
10% owner
Sold, plan not stated
1,874,203
$48.73M
100%
PASG Passage BIO, Inc.
28 Feb 2020
10% owner
Bought
373,300
$6.72M
opened
ARQT Arcutis Biotherapeutics, Inc.
3 Feb 2020
Director
Bought
558,888
$9.50M
opened
ALEC Alector, Inc.
9 Jan 2020
10% owner
Sold, plan not stated
379,997
$7.41M
90.7%
ALEC Alector, Inc.
26 Dec 2019
10% owner
Sold, plan not stated
10,800
$200.88K
21.2%
ALEC Alector, Inc.
24 Dec 2019
10% owner
Sold, plan not stated
71,800
$1.41M
63.4%
ALEC Alector, Inc.
23 Dec 2019
10% owner
Sold, plan not stated
94,285
$1.87M
65.6%
ALEC Alector, Inc.
20 Dec 2019
10% owner
Sold, plan not stated
342,500
$6.73M
85.1%
ALEC Alector, Inc.
17 Dec 2019
10% owner
Sold, plan not stated
954,100
$17.67M
90.7%
INSP Inspire Medical Systems, Inc.
27 Nov 2019
Director
Sold, plan not stated
53,387
$3.82M
3.8%
INSP Inspire Medical Systems, Inc.
26 Nov 2019
Director
Sold, plan not stated
70,613
$4.94M
4.8%
TELA TELA Bio, Inc.
8 Nov 2019
10% owner
Bought
384,615
$5.00M
32.5%
ALEC Alector, Inc.
7 Aug 2019
10% owner
Sold, plan not stated
650,000
$11.64M
18.0%
CRVS Corvus Pharmaceuticals, Inc.
6 Aug 2019
Director
Bought
142,656
$500.72K
2.2%
CRVS Corvus Pharmaceuticals, Inc.
1 Jul 2019
Director
Bought
59,243
$231.64K
0.9%
CRVS Corvus Pharmaceuticals, Inc.
28 Jun 2019
Director
Bought
565,178
$2.10M
9.4%
CRVS Corvus Pharmaceuticals, Inc.
27 Jun 2019
Director
Bought
32,923
$109.96K
0.6%
NXTC NextCure, Inc.
13 May 2019
Director
Bought
350,000
$5.25M
14.8%
INSP Inspire Medical Systems, Inc.
8 Mar 2019
Director
Sold, plan not stated
290,231
$16.76M
16.5%
INSP Inspire Medical Systems, Inc.
7 Mar 2019
Director
Sold, plan not stated
68,218
$3.75M
3.7%
ALEC Alector, Inc.
11 Feb 2019
Director
Bought
411,700
$7.82M
4.1%
SIBN SI-BONE, Inc.
19 Oct 2018
Director
Bought
200,000
$3.00M
25.5%
WHWK Whitehawk Therapeutics, Inc.
28 Jun 2018
Director
Bought
777,500
$2.99M
17.6%
RYTM RHYTHM PHARMACEUTICALS, INC.
22 May 2018
10% owner
Sold, plan not stated
19,580
$595.77K
0.7%
RYTM RHYTHM PHARMACEUTICALS, INC.
21 May 2018
10% owner
Sold, plan not stated
62,500
$1.94M
2.2%
RYTM RHYTHM PHARMACEUTICALS, INC.
18 May 2018
10% owner
Sold, plan not stated
69,136
$2.13M
2.4%
INSP Inspire Medical Systems, Inc.
7 May 2018
10% owner
Bought
312,500
$5.00M
14.7%
PVLA PALVELLA THERAPEUTICS, INC.
30 Apr 2018
10% owner
Sold, plan not stated
1,000,000
$6.35M
96.3%
CRVS Corvus Pharmaceuticals, Inc.
12 Mar 2018
Director
Bought
588,235
$5.00M
10.9%
GKOS GLAUKOS Corp
6 Mar 2018
Director
Sold, plan not stated
161,321
$4.95M
100%
GKOS GLAUKOS Corp
5 Mar 2018
Director
Sold, plan not stated
210,596
$6.83M
99.3%
GKOS GLAUKOS Corp
2 Mar 2018
Director
Sold, plan not stated
464,583
$15.00M
99.2%
XTNT Xtant Medical Holdings, Inc.
14 Feb 2018
Director
Bought
945,819
$6.81M
19.1%
PVLA PALVELLA THERAPEUTICS, INC.
13 Feb 2018
10% owner
Sold, plan not stated
7,897
$70.92K
13.8%
KALA KALA BIO, Inc.
8 Feb 2018
10% owner
Bought
25,000
$323.25K
0.7%
KALA KALA BIO, Inc.
2 Feb 2018
10% owner
Bought
37,840
$557.38K
1.1%
KALA KALA BIO, Inc.
1 Feb 2018
10% owner
Bought
22,840
$342.37K
0.7%
KALA KALA BIO, Inc.
31 Jan 2018
10% owner
Bought
339,400
$5.09M
11.2%
ACET Adicet Bio, Inc.
30 Jan 2018
Director
Bought
533,333
$8.00M
12.4%
KALA KALA BIO, Inc.
29 Jan 2018
10% owner
Bought
50,000
$749.50K
1.7%
KALA KALA BIO, Inc.
26 Jan 2018
10% owner
Bought
22,760
$339.81K
0.8%
KALA KALA BIO, Inc.
24 Jan 2018
10% owner
Bought
64,637
$963.74K
2.2%
KALA KALA BIO, Inc.
23 Jan 2018
10% owner
Bought
4,363
$65.40K
0.2%
KALA KALA BIO, Inc.
22 Jan 2018
10% owner
Bought
75,000
$1.12M
2.7%
KALA KALA BIO, Inc.
19 Jan 2018
10% owner
Bought
74,931
$1.12M
2.7%
KALA KALA BIO, Inc.
12 Jan 2018
10% owner
Bought
66,800
$994.20K
2.5%
KALA KALA BIO, Inc.
11 Jan 2018
10% owner
Bought
41,700
$569.21K
1.6%
KALA KALA BIO, Inc.
10 Jan 2018
10% owner
Bought
170,338
$2.19M
6.9%
PVLA PALVELLA THERAPEUTICS, INC.
3 Jan 2018
10% owner
Sold, plan not stated
1,709,620
$12.57M
97.2%
PVLA PALVELLA THERAPEUTICS, INC.
18 Dec 2017
10% owner
Sold, plan not stated
147,635
$841.52K
69.3%
RYTM RHYTHM PHARMACEUTICALS, INC.
10 Oct 2017
10% owner
Bought
355,000
$6.04M
13.9%
GKOS GLAUKOS Corp
5 Sep 2017
Director
Sold, plan not stated
425,200
$16.62M
98.2%
GKOS GLAUKOS Corp
1 Sep 2017
Director
Sold, plan not stated
110,078
$4.15M
90.2%
GKOS GLAUKOS Corp
31 Aug 2017
Director
Sold, plan not stated
44,922
$1.70M
77.6%
GKOS GLAUKOS Corp
17 Aug 2017
Director
Sold, plan not stated
226,920
$8.59M
94.4%
GKOS GLAUKOS Corp
16 Aug 2017
Director
Sold, plan not stated
65,580
$2.49M
80.9%
GKOS GLAUKOS Corp
15 Aug 2017
Director
Sold, plan not stated
32,500
$1.24M
66.8%
KALA KALA BIO, Inc.
25 Jul 2017
10% owner
Bought
319,333
$4.79M
15.5%
WHWK Whitehawk Therapeutics, Inc.
15 Mar 2017
Director
Bought
762,995
$3.81M
20.9%
GKOS GLAUKOS Corp
14 Mar 2017
Director
Sold, plan not stated
74,100
$3.30M
81.8%
GKOS GLAUKOS Corp
13 Mar 2017
Director
Sold, plan not stated
211,410
$9.58M
92.5%
GKOS GLAUKOS Corp
10 Mar 2017
Director
Sold, plan not stated
97,028
$4.46M
83.5%
GKOS GLAUKOS Corp
3 Mar 2017
Director
Sold, plan not stated
55,772
$2.62M
73.6%
SYRE Spyre Therapeutics, Inc.
21 Feb 2017
10% owner
Bought
7,000
$37.52K
0.5%
SYRE Spyre Therapeutics, Inc.
17 Feb 2017
10% owner
Bought
71,800
$372.64K
5.2%
SYRE Spyre Therapeutics, Inc.
16 Feb 2017
10% owner
Bought
30,500
$153.72K
2.2%
GKOS GLAUKOS Corp
12 Aug 2016
Director
Sold, plan not stated
14,100
$475.45K
40.7%
GKOS GLAUKOS Corp
11 Aug 2016
Director
Sold, plan not stated
160,900
$5.41M
88.6%
GKOS GLAUKOS Corp
10 Aug 2016
Director
Sold, plan not stated
117,938
$3.98M
84.1%
GKOS GLAUKOS Corp
3 Aug 2016
Director
Sold, plan not stated
425,000
$13.00M
94.8%
RNAC Cartesian Therapeutics, Inc.
27 Jun 2016
Director
Bought
1,100,000
$15.40M
152%
CRVS Corvus Pharmaceuticals, Inc.
24 Jun 2016
Director
Bought
900
$11.69K
0.0%
CRVS Corvus Pharmaceuticals, Inc.
23 Jun 2016
Director
Bought
100
$1.29K
0.0%
CRVS Corvus Pharmaceuticals, Inc.
21 Jun 2016
Director
Bought
26,083
$335.69K
0.5%
CRVS Corvus Pharmaceuticals, Inc.
17 Jun 2016
Director
Bought
12,300
$153.50K
0.2%
CRVS Corvus Pharmaceuticals, Inc.
16 Jun 2016
Director
Bought
5,000
$60.20K
0.1%
CRVS Corvus Pharmaceuticals, Inc.
15 Jun 2016
Director
Bought
5,000
$59.70K
0.1%
CRVS Corvus Pharmaceuticals, Inc.
14 Jun 2016
Director
Bought
10,000
$127.10K
0.2%
CRVS Corvus Pharmaceuticals, Inc.
10 Jun 2016
Director
Bought
20,000
$259.60K
0.4%
CRVS Corvus Pharmaceuticals, Inc.
9 Jun 2016
Director
Bought
30,000
$388.50K
0.6%
CRVS Corvus Pharmaceuticals, Inc.
20 May 2016
Director
Bought
4,716
$61.73K
0.1%
CRVS Corvus Pharmaceuticals, Inc.
19 May 2016
Director
Bought
2,600
$31.53K
0.0%
CRVS Corvus Pharmaceuticals, Inc.
18 May 2016
Director
Bought
4,200
$48.51K
0.1%
NTLA Intellia Therapeutics, Inc.
11 May 2016
Director
Bought
250,000
$4.50M
10.4%
CRVS Corvus Pharmaceuticals, Inc.
29 Mar 2016
Director
Bought
550,000
$8.25M
11.7%
PVLA PALVELLA THERAPEUTICS, INC.
6 Jul 2015
Director
Bought
500,000
$1.38M
7.5%
SUPN SUPERNUS PHARMACEUTICALS, INC.
13 Feb 2013
10% owner
Sold, plan not stated
150,000
$1.14M
15.5%
SUPN SUPERNUS PHARMACEUTICALS, INC.
12 Feb 2013
10% owner
Sold, plan not stated
152,183
$1.14M
15.1%
SUPN SUPERNUS PHARMACEUTICALS, INC.
18 Dec 2012
10% owner
Sold, plan not stated
100,000
$707.67K
100%
SUPN SUPERNUS PHARMACEUTICALS, INC.
17 Dec 2012
10% owner
Sold, plan not stated
197,815
$1.35M
66.4%
AMRN AMARIN CORP PLC\UK
4 Sep 2012
Director
Sold, plan not stated
233,700
$3.37M
97.6%
AMRN AMARIN CORP PLC\UK
27 Jul 2012
Director
Sold, plan not stated
362,844
$5.30M
30.5%
AMRN AMARIN CORP PLC\UK
27 Jul 2012
Director
Sold, plan not stated
3,456
$50.48K
30.3%
AMRN AMARIN CORP PLC\UK
19 Jun 2012
Director
Sold, plan not stated
611,200
$7.89M
34.0%
AMRN AMARIN CORP PLC\UK
19 Jun 2012
Director
Sold, plan not stated
5,900
$76.18K
34.1%
SUPN SUPERNUS PHARMACEUTICALS, INC.
4 May 2012
Director
Bought
1,100,000
$5.50M
84.4%
PCRX Pacira BioSciences, Inc.
12 Mar 2012
10% owner
Sold, plan not stated
63,100
$696.11K
2.5%
PCRX Pacira BioSciences, Inc.
9 Mar 2012
10% owner
Sold, plan not stated
37,000
$416.09K
1.5%
PCRX Pacira BioSciences, Inc.
29 Feb 2012
10% owner
Sold, plan not stated
3,000
$32.58K
0.1%
PCRX Pacira BioSciences, Inc.
28 Feb 2012
10% owner
Sold, plan not stated
10,100
$112.32K
0.4%
PCRX Pacira BioSciences, Inc.
27 Feb 2012
10% owner
Sold, plan not stated
29,000
$320.37K
1.1%
PCRX Pacira BioSciences, Inc.
3 Feb 2012
10% owner
Sold, plan not stated
50,000
$539.52K
1.9%
PCRX Pacira BioSciences, Inc.
2 Feb 2012
10% owner
Sold, plan not stated
23,300
$252.92K
0.9%
PCRX Pacira BioSciences, Inc.
1 Feb 2012
10% owner
Sold, plan not stated
70,000
$770.41K
2.6%
PCRX Pacira BioSciences, Inc.
31 Oct 2011
10% owner
Sold, plan not stated
97,441
$1.03M
3.4%
AMRN AMARIN CORP PLC\UK
2 May 2011
Director
Sold, plan not stated
32,600
$531.38K
1.8%
AMRN AMARIN CORP PLC\UK
2 May 2011
Director
Sold, plan not stated
300
$4.89K
1.7%
AMRN AMARIN CORP PLC\UK
29 Apr 2011
Director
Sold, plan not stated
99,000
$1.58M
5.1%
AMRN AMARIN CORP PLC\UK
29 Apr 2011
Director
Sold, plan not stated
1,000
$16.01K
5.4%
AMRN AMARIN CORP PLC\UK
21 Apr 2011
Director
Sold, plan not stated
742,900
$12.38M
27.8%
AMRN AMARIN CORP PLC\UK
21 Apr 2011
Director
Sold, plan not stated
7,100
$118.33K
27.6%
AMRN AMARIN CORP PLC\UK
20 Apr 2011
Director
Sold, plan not stated
800,000
$12.63M
96.9%
AMRN AMARIN CORP PLC\UK
18 Apr 2011
Director
Sold, plan not stated
2,971,800
$45.12M
46.2%
AMRN AMARIN CORP PLC\UK
18 Apr 2011
Director
Sold, plan not stated
28,200
$428.17K
45.9%
AMRN AMARIN CORP PLC\UK
28 Mar 2011
Director
Sold, plan not stated
92,200
$677.67K
1.4%
AMRN AMARIN CORP PLC\UK
28 Mar 2011
Director
Sold, plan not stated
900
$6.62K
1.4%
AMRN AMARIN CORP PLC\UK
25 Mar 2011
Director
Sold, plan not stated
56,400
$421.31K
0.9%
AMRN AMARIN CORP PLC\UK
25 Mar 2011
Director
Sold, plan not stated
500
$3.74K
0.8%
AMRN AMARIN CORP PLC\UK
24 Mar 2011
Director
Sold, plan not stated
22,800
$171.00K
0.3%
AMRN AMARIN CORP PLC\UK
24 Mar 2011
Director
Sold, plan not stated
200
$1.50K
0.3%
AMRN AMARIN CORP PLC\UK
21 Mar 2011
Director
Sold, plan not stated
76,300
$537.92K
1.1%
AMRN AMARIN CORP PLC\UK
21 Mar 2011
Director
Sold, plan not stated
700
$4.94K
1.1%
AMRN AMARIN CORP PLC\UK
15 Mar 2011
Director
Sold, plan not stated
49,500
$358.38K
0.7%
AMRN AMARIN CORP PLC\UK
15 Mar 2011
Director
Sold, plan not stated
500
$3.62K
0.8%
AMRN AMARIN CORP PLC\UK
14 Mar 2011
Director
Sold, plan not stated
74,300
$544.62K
1.1%
AMRN AMARIN CORP PLC\UK
14 Mar 2011
Director
Sold, plan not stated
700
$5.13K
1.1%
AMRN AMARIN CORP PLC\UK
11 Mar 2011
Director
Sold, plan not stated
99,100
$736.31K
1.4%
AMRN AMARIN CORP PLC\UK
11 Mar 2011
Director
Sold, plan not stated
900
$6.69K
1.4%
AMRN AMARIN CORP PLC\UK
7 Mar 2011
Director
Sold, plan not stated
24,800
$190.46K
0.4%
AMRN AMARIN CORP PLC\UK
7 Mar 2011
Director
Sold, plan not stated
200
$1.54K
0.3%
AMRN AMARIN CORP PLC\UK
4 Mar 2011
Director
Sold, plan not stated
42,600
$324.61K
0.6%
AMRN AMARIN CORP PLC\UK
4 Mar 2011
Director
Sold, plan not stated
400
$3.05K
0.6%
AMRN AMARIN CORP PLC\UK
3 Mar 2011
Director
Sold, plan not stated
6,900
$53.54K
0.1%
AMRN AMARIN CORP PLC\UK
3 Mar 2011
Director
Sold, plan not stated
100
$776.00
0.2%
AMRN AMARIN CORP PLC\UK
2 Mar 2011
Director
Sold, plan not stated
94,100
$726.45K
1.3%
AMRN AMARIN CORP PLC\UK
2 Mar 2011
Director
Sold, plan not stated
900
$6.95K
1.3%
AMRN AMARIN CORP PLC\UK
1 Mar 2011
Director
Sold, plan not stated
49,500
$374.22K
0.7%
AMRN AMARIN CORP PLC\UK
1 Mar 2011
Director
Sold, plan not stated
500
$3.78K
0.7%
AMRN AMARIN CORP PLC\UK
28 Feb 2011
Director
Sold, plan not stated
99,100
$766.04K
1.4%
AMRN AMARIN CORP PLC\UK
28 Feb 2011
Director
Sold, plan not stated
900
$6.96K
1.3%
PCRX Pacira BioSciences, Inc.
8 Feb 2011
10% owner
Bought
530,661
$3.71M
23.1%
PCRX Pacira BioSciences, Inc.
8 Feb 2011
10% owner
Bought
5,053
$35.37K
0.2%
356 decisions on file.